MedPath

Pain AND Opioids After Surgery

Recruiting
Conditions
Pain, Postoperative
Opioid Use
Quality of Life
Pain, Chronic
Registration Number
NCT05877157
Lead Sponsor
University of Aberdeen
Brief Summary

The aim of this study is to document the perioperative opioid use and its safety in the UK and countries in Europe and to describe its association with surgical complications, persistent pain and quality of life. In an international, prospective, observational cohort study, data about the perioperative pain management will be collected in all eligible hospitalised adult patients who undergo surgery in a designated "study week" in as many hospitals as possible in Europe. Baseline data will be collected, and participants followed up at one week, and at three and twelve months post-operatively. The primary outcome will be opioid use at three months after surgery. Secondary outcomes will include opioid use during the preoperative month (preoperative use), during surgery and up to one week after surgery (or discharge, whichever is earlier), and up to the end of the postoperative year. Additional secondary outcomes are the incidence of preoperative pain, persistent pain with/without the presence of neuropathic components, quality of life and surgical complications. The potential association between opioid use and pain outcomes will be investigated. This study could help to develop strategies to improve quality of care, through pain management, for patients undergoing surgery.

Detailed Description

PANDOS is an international, prospective, observational cohort study. In a one week period (the designated "study week"), data will be collected in all eligible hospitalised adult patients who undergo surgery in as many hospitals as possible in the UK and Europe. Participants will be followed up for 12 months

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
10000
Inclusion Criteria
  • hospitalised adult patients (18 years and older) undergoing any inpatient surgery (elective or emergency) during the designated study week where an anaesthetist is involved (general anaesthetic, sedation, local anaesthetic).

Able to understand and has capacity to give written informed consent

Exclusion Criteria
  • American Society of Anaesthesiologists (ASA) grade V or VI
  • Refusal to participate.
  • Lack of comprehension of validated questionnaires or inability to complete the follow-up for any reason.
  • Lack of capacity to give written informed consent

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Patient reported Opioid use post surgery3 months

Patient reported use of opioids post surgery

Secondary Outcome Measures
NameTimeMethod
Opioid useFrom recruitment to 1 year post surgery

Patient reported use of opioids pre-op and opioids used during surgery and prescribed post surgery

Patient reported incidence of pain pre-op and post surgery using BPI-SFFrom recruitment to 1 year post surgery

Patient reported incidence of pain pre-op and post surgery using BPI-SF

Patient reported incidence of pain pre-op and post surgery using DN2From recruitment to 1 year post surgery

Patient reported incidence of pain pre-op and post surgery using DN2

Surgical complicationsDuring surgery

Recording of surgical complications during surgery

Participant reported quality of life EQ5D-5LFrom recruitment to 1 year post surgery

EQ5D-5L

Participant reported quality of life BPI-SFFrom recruitment to 1 year post surgery

BPI-SF

Trial Locations

Locations (4)

Department of Anaesthesiology Sestre Milosrdnice, University Hospital Center

🇭🇷

Zagreb, Vinogradska 29, Croatia

NHS Grampian

🇬🇧

Aberdeen, United Kingdom

University College London Hospitals NHS Foundation Trust

🇬🇧

London, United Kingdom

Kings Mill Hospital, Sherwood Forest Hospitals NHS Foundation Trust

🇬🇧

Nottingham, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath